Imexpharm Corp Capital Reinvestment Ratio
Imexpharm Corp capital reinvestment ratio. Imexpharm Corp (IMP) has a Capital Reinvestment Ratio of 0.30x as of June 2026, meaning it reinvests 0% of its operating cash flow (₫55.75 Billion) in capital expenditures (₫16.90 Billion). See Imexpharm Corp free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Imexpharm Corp (2019–2025)
Capital reinvestment ratio of Imexpharm Corp from 2019 to 2025. This chart tracks Imexpharm Corp's Capital Reinvestment Ratio across 6 annual periods. See IMP free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Imexpharm Corp Capital Reinvestment Ratio by Year (2019–2025)
Imexpharm Corp capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Imexpharm Corp.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.50x | ₫54.17 Billion | ₫26.88 Billion | ▲ +10.9% |
| 2024 | 0.45x | ₫216.27 Billion | ₫96.77 Billion | ▲ +70.5% |
| 2022 | 0.26x | ₫378.60 Billion | ₫99.35 Billion | ▲ +16.6% |
| 2021 | 0.23x | ₫234.88 Billion | ₫52.86 Billion | ▼ -81.6% |
| 2020 | 1.23x | ₫73.15 Billion | ₫89.68 Billion | ▼ -37.7% |
| 2019 | 1.97x | ₫66.59 Billion | ₫131.12 Billion | — |